Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference GlobeNewswire December 11, 2025 RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases, announced […]